FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
ENT & Allergy – 2024 Update: Conservative Pace Continues
ENT & Allergy – 2024 Update: Conservative Pace Continues
Summary
Private equity-backed Physician Practice Management (“PPM”) companies in the... Read more.
Ophthalmology – 2024 Update: Entering a Mature Stage
Ophthalmology – 2024 Update: Entering a Mature Stage
Summary
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle... Read more.
Ophthalmology 2024 Update
Ophthalmology 2024 Update
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We expect continued transaction... Read more.
FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
Washington, DC, (November 30, 2023)... Read more.
How to Manage Risks When Selling Your Physician Practice
How to Manage Risks When Selling Your Physician Practice
Based on the large number of medical practices acquired over the past decade, you may think selling... Read more.
How to Value a Medical Practice: What Really Matters
How to Value a Medical Practice: What Really Matters
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent,... Read more.
ENT & Allergy Practices Attract Private Equity
ENT & Allergy Practices Attract Private Equity
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted... Read more.
Private Equity Interest in Orthopedics Grows
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been... Read more.
Private Equity’s Increasing Consolidation of Oncology Practices
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued... Read more.
M&A Ophthalmology Deals Continue Into 2023 with Small And Mid-Size Transactions
The first quarter of 2023 delivered ten reported ophthalmology practice acquisitions, which aligns with seasonal acquisition trends (Q1 of 2022 reported eleven deals).... Read more.
What’s the Best Order to Sell?
What's the Best Order to Sell?
The million-dollar question is, which came first, the chicken or the egg? The practice sale or the real estate sale? An investment... Read more.
OPHTHALMOLOGY: A Great Time for Sellers to Do a Deal
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller... Read more.
Setting Your Rent as Part of a PE Deal
Setting Your Rent as Part of a PE Deal
Pick a rent, any rent? Setting your rent to the magic number is more important than you think. Having a trusted advisor... Read more.